Candriam S.C.A. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$14,472,000
-3.9%
130,5470.0%0.12%
+0.8%
Q4 2020$15,067,000
+42.7%
130,547
+20.4%
0.12%
+20.2%
Q3 2020$10,555,000
-28.3%
108,427
-9.6%
0.10%
-36.1%
Q2 2020$14,722,000
+90.0%
119,962
+58.2%
0.16%
+80.2%
Q1 2020$7,749,000
-2.2%
75,8110.0%0.09%
+1.2%
Q4 2019$7,927,000
+34.6%
75,811
+48.1%
0.08%
+9.0%
Q3 2019$5,890,000
-33.0%
51,2000.0%0.08%
-29.1%
Q2 2019$8,788,000
+26.5%
51,200
+24.3%
0.11%
+23.6%
Q1 2019$6,945,000
+73.1%
41,2000.0%0.09%
+43.5%
Q4 2018$4,012,000
-36.6%
41,200
+12.5%
0.06%
-26.2%
Q3 2018$6,326,000
+74.9%
36,620
+41.3%
0.08%
+47.4%
Q2 2018$3,617,000
+37.1%
25,920
+10.7%
0.06%
+26.7%
Q1 2018$2,639,000
-13.1%
23,420
+1.8%
0.04%
-15.1%
Q4 2017$3,036,000
+3.2%
23,000
-20.7%
0.05%
+3.9%
Q3 2017$2,943,000
+22.3%
29,000
+20.8%
0.05%
+13.3%
Q2 2017$2,406,000
+17.0%
24,000
+41.2%
0.04%
+12.5%
Q1 2017$2,056,000
+31.5%
17,000
+21.4%
0.04%
+11.1%
Q4 2016$1,564,000
+7.1%
14,000
+27.3%
0.04%
+2.9%
Q3 2016$1,460,000
-0.3%
11,000
-31.2%
0.04%
-7.9%
Q2 2016$1,465,00016,0000.04%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders